# GE HealthCare Technologies Inc. – Consensus ‘buy’ rating and 9.7% Upside Potential

- Link: https://www.directorstalkinterviews.com/ge-healthcare-technologies-inc.consensus-buy-rating-and-9.7-upside-potential/4121151786
- Published: 2024-04-16T12:22:54+01:00
- Author: Charlotte Edwards

**GE HealthCare Technologies Inc.** with ticker code (GEHC) now have 13 confirmed
analysts covering the stock with the consensus suggesting a rating of ‘buy’. The
target price High/Low ranges between $103.00 and $86.00 calculating the mean target
price we have $94.63. Given that the stocks previous close was at $86.28 this is
indicating there is a potential upside of 9.7%. The 50 day MA is $87.88 and the 
200 day moving average is $75.97. The market cap for the company is 39.30B. The 
current share price for the company is: $86.13 USD

 The potential market cap would be $43,107,242,664 based on the market consensus.

The company has a dividend yield of 0.77%. Other points of data to note are a P/
E ratio of 28.33, revenue per share of $42.97 and a 6.15% return on assets.

GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics,
and digital solutions company. The Company develops, manufactures, and markets a
portfolio of products, services, and complementary digital solutions used in the
diagnosis, treatment, and monitoring of patients. The Company’s segments include
Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The 
Imaging segment includes scanning devices, clinical applications, service capabilities
and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment,
and monitoring of certain diseases. The Patient Care Solutions segment includes 
medical devices, services, consumable products, services, and digital solutions.
The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the
global radiology and nuclear medicine industry.

Share on: